Inventor · disambiguated record
Kenneth C. Mcnulty
Also filed as: MCNULTY KENNETH C
4 granted patents·4 pending applications·62 citations·filing 1997–2016
73Inventor score
Files withBRISTOL MYERS SQUIBB PHARMA CO2GLAXOSMITHKLINE IP NO 2 LTD2GLAXOSMITHKLINE LLC2DU PONT1NOVARTIS AG1
Top patents by PatentIndex Score
8 records- 0188US5847191AProcess for the hydrocyanation of monoolefins using bidentate phosphite ligands and zero-valent nickelDU PONT·Filed 1997·Granted Dec 8, 1998·57 cites·14 claims
- 0281US8946278B2Inhibitors of AkT activityGLAXOSMITHKLINE LLC·Filed 2013·Granted Feb 3, 2015·3 cites·15 claims
- 0364US2015152092A1INHIBITORS OF Akt ACTIVITYGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 0461US7208596B2Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereofBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Apr 24, 2007·2 cites·10 claims
- 0558US2016287561A1Inhibitors of AKT ActivityNOVARTIS AG·Filed 2016·Application pending·0 cites
- 0651US7442792B2Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereofBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Granted Oct 28, 2008·0 cites·18 claims
- 0744US2016122342A1Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2014·Application pending·0 cites
- 0836US2018162845A1Enhancer of zeste homolog 2 inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →